Trial
NCT03874234
Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Leishmaniasis
Intervention
GSK3186899
Why stopped
The trial was terminated early following strategic review after emergence of nonclinical data with a non-GlaxoSmithKline asset.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-27